Wang B - Search Results

1

LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.

Thomasson M, Wang B, Hammarsten P, Dahlman A, Persson JL, Josefsson A, Stattin P, Granfors T, Egevad L, Henriksson R, Bergh A, Hedman H. Thomasson M, et al. Among authors: wang b. Int J Cancer. 2011 Jun 15;128(12):2843-52. doi: 10.1002/ijc.25820. Epub 2011 Apr 8. Int J Cancer. 2011. PMID: 21128282

2

Lrig2-deficient mice are protected against PDGFB-induced glioma.

Rondahl V, Holmlund C, Karlsson T, Wang B, Faraz M, Henriksson R, Hedman H. Rondahl V, et al. Among authors: wang b. PLoS One. 2013 Sep 4;8(9):e73635. doi: 10.1371/journal.pone.0073635. eCollection 2013. PLoS One. 2013. PMID: 24023893 Free PMC article.

3

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.

Johansson M, Oudin A, Tiemann K, Bernard A, Golebiewska A, Keunen O, Fack F, Stieber D, Wang B, Hedman H, Niclou SP. Johansson M, et al. Among authors: wang b. Neuro Oncol. 2013 Sep;15(9):1200-11. doi: 10.1093/neuonc/not054. Epub 2013 May 30. Neuro Oncol. 2013. PMID: 23723255 Free PMC article.

4

A role for LRIG1 in the regulation of malignant glioma aggressiveness.

Mao F, Wang B, Xiao Q, Xi G, Sun W, Zhang H, Ye F, Wan F, Guo D, Lei T, Chen X. Mao F, et al. Among authors: wang b. Int J Oncol. 2013 Mar;42(3):1081-7. doi: 10.3892/ijo.2013.1776. Epub 2013 Jan 16. Int J Oncol. 2013. PMID: 23337938

5

Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.

Xie R, Yang H, Xiao Q, Mao F, Zhang S, Ye F, Wan F, Wang B, Lei T, Guo D. Xie R, et al. Among authors: wang b. Oncol Rep. 2013 Jan;29(1):177-84. doi: 10.3892/or.2012.2102. Epub 2012 Oct 23. Oncol Rep. 2013. PMID: 23124613

6

Effects of RNAi-mediated gene silencing of LRIG1 on proliferation and invasion of glioma cells.

Mao F, Wang B, Xi G, Sun W, Zhang H, Ye F, Guo D, Lei T. Mao F, et al. Among authors: wang b. J Huazhong Univ Sci Technolog Med Sci. 2012 Apr;32(2):227-232. doi: 10.1007/s11596-012-0040-8. Epub 2012 Apr 20. J Huazhong Univ Sci Technolog Med Sci. 2012. PMID: 22528225

7

LRIG1 enhances cisplatin sensitivity of glioma cell lines.

Wang X, Xiao Q, Xing X, Tian C, Zhang H, Ye F, Wan F, Wang B, Guo D, Lei T. Wang X, et al. Among authors: wang b. Oncol Res. 2012;20(5-6):205-11. doi: 10.3727/096504013x13589503482770. Oncol Res. 2012. PMID: 23581227

8

Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.

Ye F, Gao Q, Xu T, Zeng L, Ou Y, Mao F, Wang H, He Y, Wang B, Yang Z, Guo D, Lei T. Ye F, et al. Among authors: wang h, wang b. J Neurooncol. 2009 Sep;94(2):183-94. doi: 10.1007/s11060-009-9836-1. Epub 2009 Mar 20. J Neurooncol. 2009. PMID: 19300910

9

Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro.

Wang B, Han L, Chen R, Cai M, Han F, Lei T, Guo D. Wang B, et al. Cancer Biol Ther. 2009 Jun;8(11):1018-23. doi: 10.4161/cbt.8.11.8375. Epub 2009 Jun 10. Cancer Biol Ther. 2009. PMID: 19421009 Free article.

10

Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15).

Cai M, Han L, Chen R, Ye F, Wang B, Han F, Lei T, Guo D. Cai M, et al. Among authors: wang b. Cancer Lett. 2009 Jun 8;278(1):104-12. doi: 10.1016/j.canlet.2009.01.001. Epub 2009 Feb 5. Cancer Lett. 2009. PMID: 19200647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,900 results

Search Page

Filters